[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [HEALTH]

2 clusters · 4 sources · 1 days · First seen · Last updated

UCI Health pancreatic cancer laser therapy trial

Overview

UCI Health is conducting a first-in-human, phase 1 clinical trial using vascular targeted photodynamic therapy (VTP) to treat localized but inoperable pancreatic tumors. Developed by Israel-based ImPact Biotech, the treatment uses a light-sensitive drug called padeliporfin to destroy tumors encasing major abdominal arteries.

The goal of the therapy is to clear these vessels of tumor tissue to make patients eligible for life-saving surgical procedures. Of the six patients treated in the trial so far, four were able to undergo surgery to remove remaining tumor tissue, with three of those patients showing no evidence of cancer cells at the surgical margins.

Entities

University of California, Irvine · ImPact Biotech · City of Hope · UCI Health · University of Adelaide

Timeline

  1. 2 days ago

    [HEALTH] 2 sources
    Medical researchers test laser therapy and mRNA nanoparticles for cancer treatment

    New medical advancements include a Phase 1 trial using laser therapy to make pancreatic tumors operable and mRNA nanoparticles designed to reprogram immune cells to fight cancer.

  2. 3 days ago

    [HEALTH] 2 sources
    UCI Health conducts clinical trial using laser therapy for pancreatic cancer

    UCI Health is conducting a phase 1 clinical trial using laser-based photodynamic therapy to target inoperable pancreatic tumors, potentially making patients eligible for life-saving surgery.

Sources

doctorulzilei.ro · news-medical.net · newswise.com · stiintasitehnica.com